Logo image
White clot syndrome associated with renal failure
Journal article   Open access

White clot syndrome associated with renal failure

D L Somers, C Sotolongo and J A Bertolatus
Journal of the American Society of Nephrology, Vol.4(2), pp.137-141
08/1993
DOI: 10.1681/ASN.V42137
PMID: 8400075
url
https://doi.org/10.1681/ASN.V42137View
Published (Version of record) Open Access

Abstract

In a minority of patients, heparin administration is associated with thrombocytopenia and this thrombocytopenia may be associated with thromboembolic events. Heparin-associated thromboembolism is described as heparin-associated thrombocytopenia and thrombosis or white clot syndrome. White clot syndrome is caused by antibodies to a heparin-platelet membrane complex. The diagnosis carries a high mortality and morbidity from limb thromboembolism. Treatment includes discontinuation of heparin, use of alternate anticoagulants, and aggressive treatment of thromboses. A case in which acute renal failure occurred in the setting of heparin treatment and thrombocytopenia is described, and evidence that renal failure was a result of white clot syndrome is provided.
Heparin - metabolism Thrombosis - chemically induced Thrombosis - complications Humans Middle Aged Carcinoma, Squamous Cell - surgery Sepsis - complications Disseminated Intravascular Coagulation - complications Heparin - adverse effects Thrombocytopenia - complications Platelet Membrane Glycoproteins - metabolism Fatal Outcome Female Renal Veins Postoperative Complications - drug therapy Acute Kidney Injury - etiology Pulmonary Embolism - complications Thrombocytopenia - immunology Thrombosis - immunology Thrombocytopenia - chemically induced Antigens, Human Platelet - immunology Syndrome Platelet Aggregation Heparin - immunology Carcinoma, Squamous Cell - complications Protein Binding Head and Neck Neoplasms - complications Pulmonary Embolism - drug therapy Head and Neck Neoplasms - surgery

Details

Metrics

Logo image